Navigation Links
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Date:9/2/2008

tical chemistry. Dr. LaBarre received his BS degree in Chemistry from Southampton College and his PhD in Bioinorganic Chemistry from the University of Arizona.

James E. Cartoni will oversee various legal matters, including the negotiation and completion of agreements, corporate governance matters, securities compliance, and the coordination and management of outside legal counsel. Prior to joining Halozyme, Mr. Cartoni was a partner at DLA Piper, the world's largest law firm, where he represented numerous public and private companies in areas such as financing transactions, corporate compliance, mergers & acquisitions and general business matters. DLA Piper is Halozyme's primary outside corporate counsel and Mr. Cartoni has represented Halozyme since 2004. Mr. Cartoni also served as the Co-Chair of the Legal and Finance Committee for the 2008 U.S. Open at Torrey Pines Golf Course. Mr. Cartoni obtained his BA degree in Political Science from Occidental College and his Juris Doctor degree from the University of California -- Hastings College of the Law in 1998.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the drug delivery, metabolism, oncology, and dermatology markets. The company's portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cumulase(R), for use in in-vitro fertilization, and HYLENEX, for use as an adjuvant
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
2. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
3. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
4. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
5. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
6. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
7. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
8. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
9. Halozyme Therapeutics Amends Stockholder Rights Plan
10. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
11. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... group at the Institute for Molecular Medicine Finland ... has developed a novel "man and machine" decision ... diagnostic aid was described in PLOS One ... is based on computer vision algorithms similar to ... visualization of only the diagnostically most relevant areas. ...
(Date:8/21/2014)... His Majesty Willem-Alexander, King of the Netherlands ... His Majesty Willem-Alexander, King of the Netherlands, has announced ... POET-DSM Advanced Biofuels’ Project LIBERTY cellulosic ethanol plant in ... will take part in the Grand Opening Ceremony to ... p.m. and tour the plant. POET-DSM is a joint ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 Mathematic ... at Harvard University , and funded by the ... aggressive cells within tumors can be visually identified for elimination. ... tumor,s growth. The study, which shows a topological map of ... needed time in cancer research, for while tumor cells can ...
(Date:8/21/2014)... August 21, 2014 Pursuit Solutions ... optimization technology and services for Life Sciences sales ... Pharma’s Use of New Commercial Sales Models” by ... Analytics. , The article examines some innovative models ... are being tested in the pharmaceutical market. Robinson ...
Breaking Biology Technology:A novel 'man and machine' decision support system makes malaria diagnostics more effective 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2
... (a wholly-owned subsidiary of AVANT,Immunotherapeutics)(Nasdaq: AVAN ) ... developed for the treatment of Glioblastoma,Multiforme (GBM), will ... the 44th,Annual Meeting of the American Society of ... at McCormick Place in Chicago from May 30 ...
... Digirad Corporation,(Nasdaq: DRAD ), a leading provider ... offices, hospitals and imaging centers, today,announced the signing ... School of Medicine in Baltimore, Md., Under ... available to read,diagnostic images for primary care physicians, ...
... Partners released our,2008 studies of executive compensation in the ... ( http://www.dolmatconnell.com ),today and issued the below press release ... some very interesting findings, summarized in the press,release, that ... If,you would like to discuss any of the findings ...
Cached Biology Technology:AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting 2AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting 3Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 2Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 3Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 4DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance 2DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance 3
(Date:8/22/2014)... the bees. But that old expression leaves out ... process for flowering plants is particularly complex and ... reproductive cells. New research from an international team ... Carnegie,s Wolf Frommer, David Ehrhardt, and Guido Grossmann ... guides flowering plant fertilization. It is published in ...
(Date:8/21/2014)... Ind. -- A new study of American singles ... men have the highest orgasm rates. On average, ... with their sexual orientation making little difference. For ... average, women experience orgasm 62.9 percent of the ... and this pattern varies with women,s sexual orientation, ...
(Date:8/21/2014)... they are the ultimate source of all organic matter ... on algae, too, to suck up climate-warming carbon dioxide ... of the ocean. Now, by using a combination of ... that viruses infecting those algae are driving the life-and-death ... stays essentially the same, and this has important implications ...
Breaking Biology News(10 mins):Calcium and reproduction go together 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4Viruses take down massive algal blooms, with big implications for climate 2
... researchers have discovered how malaria parasites persuade red blood cells ... parasites. The malaria marauders hack into the red cell's signaling ... spring open the door to the cell. But researchers have ... signal to prevent the parasite from breaking in. ...
... human mothers are probably happy that they typically have one, ... low birth numbers combined with competition often spelled extinction. , ... hard for them to respond to rapid perturbations in the ... department head at Penn State. "Through time we see ...
... very small. , Nano small. , A Michigan State ... polymer films from buckling and wrinkling. It's a new solution ... in new technology such as electronic monitors. , ... seems crossed with science fiction ?from microdermabrasians to lasers ...
Cached Biology News:Researchers discover surprising drug that blocks malaria 2Birth rate, competition are major players in hominid extinctions 2Birth rate, competition are major players in hominid extinctions 3Nanotechnology shows promise as next wrinkle fighter 2
... A high quality source of ... the enzymatic digestion of casein. It ... fermentations and has been used in ... casein, pancreatic digest For microbiology pH6.8 ...
... Human Raji cells were cultured in RPMI 1640 ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... mini incubation trays are disposable ... screen antigens that have been ... tray has eight 10.5 cm ... accommodate strips cut from blotted ...
Biology Products: